United States Connected Drug Delivery Devices Market to be dominated by Technology segment through 2028

Increasing cases of asthma expected to drive the United States Connected Drug Delivery Devices Market in the forecast period, 2022-2028.

According to TechSci Research report, “United States Connected Drug Delivery Devices – By Region, Competition Forecast and Opportunities, 2018-2028,” the United States Connected Drug Delivery Devices market is expected to grow at a steady rate during the forecast period, 2018-2028. The increase in prevalence of chronic diseases, increase in R&D activities, and growing awareness amongst patients to boost medication are the primary factors driving the demand for the United States Connected Drug Delivery Devices Market. In the United States, asthma resulted in an estimation of around 1.6 million emergency department (ED) visits and 183,000 hospitalizations in 2017.

Moreover, the advancement in technology has led to an improvement in the treatment of serious infectious diseases, which will enhance the growth of the market in the forecast period.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "UnitedStates Connected Drug Delivery Devices Market”

The United States Connected Drug Delivery Devices Market can be segmented by product type, technology, application, end user, region and competitive landscape.

Based on product type, the market can be segmented into connected sensors, and integrated connected devices. The connected sensors segment is expected to dominate the market and hold the largest market share in the forecast period. This can be ascribed to the increased development of technology and modification of devices and connected sensors, which can be integrated with the existing conventional drug delivery systems.

Based on technology, the market is segmented into bluetooth, near field communication, and others. The bluetooth segment is expected to dominate the market in the forecast period on account of its high usability, ease in processing and low additional cost.

By end user, the market can be categorized into healthcare providers, homecare.

Major companies operating in the United States Connected Drug Delivery Devices Market include:

• Abbott Laboratories, Inc.
• F. Hoffmann-La Roche Ltd. (USA)
• Reciprocal Labs Corporation (Propeller Health)
• Teva USA
• Merck & Co.
• West Pharmaceutical Services, Inc.
• Molex LLC (Phillips Medisize)
• Cohero Health, Inc.
• Becton, Dickinson, and Company
• Unilife Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“United States Connected Drug Delivery Devices Market is expected to witness significant growth during the forecast period on account of growing healthcare expenditure and technological advancement, that further supports the demand for connected drug delivery devices in the United States. Additionally, mergers and acquisitions with the global giants is expected to create lucrative opportunities for the market growth in the next few years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United States Connected Drug Delivery Devices Market By Product Type (Connected Sensors v/s Integrated Connected Devices), By Technology (Bluetooth, Near Field Communication, Others), By Application (Asthma & COPD, Diabetes, Others), By End User (Healthcare Providers v/s Homecare) By Region, Competition, Forecast & Opportunities, 2028F” has evaluated the future growth potential of United States Connected Drug Delivery Devices Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Connected Drug Delivery Devices Market.